Adamis an­nounces merg­er four months af­ter PhII/III miss

In a bid to stay afloat, Adamis Phar­ma­ceu­ti­cals will merge with DMK Phar­ma­ceu­ti­cals. The merg­er comes just four months af­ter its stock crashed fol­low­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.